Captiva Spine receives FDA 510(k) clearance for 3-D printed titanium lumbar cages

Captiva Spine announced it has received FDA 510(k) clearance for its TirboLOX-L 3-D printed titanium lumbar cages.

According to a press release, the titanium lumbar interbody fusion cages were developed with 3-D printing technology to create titanium alloy devices with a dual later organic lattice structure. The TirboLOX-L cages have an open architecture which reportedly can reduce their radiographic presence for clear imaging. They also have a high coefficient of friction that allows for immediate bidirectional fixation.

“With the advanced capabilities of 3-D additive manufacturing, we were able to create a unique lattice structure similar to trabecular bone incorporating a micro-rough surface for clot retention and early osteogenic cell migration, including a dual layer of porosity with pore sizes specifically designed to promote bone ingrowth and vascularization,” Dennis Ty, director of research and development at Captiva Spine, said in the release. “Through substantial surgeon design input, we are able to deliver TirboLOX-L’s unique dual layer organic lattice structure with numerous geometries and sizes that appeal to a wide range of surgeon preferences.”

Reference:

www.captivaspine.com

Captiva Spine announced it has received FDA 510(k) clearance for its TirboLOX-L 3-D printed titanium lumbar cages.

According to a press release, the titanium lumbar interbody fusion cages were developed with 3-D printing technology to create titanium alloy devices with a dual later organic lattice structure. The TirboLOX-L cages have an open architecture which reportedly can reduce their radiographic presence for clear imaging. They also have a high coefficient of friction that allows for immediate bidirectional fixation.

“With the advanced capabilities of 3-D additive manufacturing, we were able to create a unique lattice structure similar to trabecular bone incorporating a micro-rough surface for clot retention and early osteogenic cell migration, including a dual layer of porosity with pore sizes specifically designed to promote bone ingrowth and vascularization,” Dennis Ty, director of research and development at Captiva Spine, said in the release. “Through substantial surgeon design input, we are able to deliver TirboLOX-L’s unique dual layer organic lattice structure with numerous geometries and sizes that appeal to a wide range of surgeon preferences.”

Reference:

www.captivaspine.com